CLK-IN-T3
Product Specifications
UNSPSC Description
CLK-IN-T3 is a high potent, selective, and stable CDC-like kinase (CLK) inhibitor with IC50s of 0.67 nM, 15 nM, and 110 nM for CLK1, CLK2, and CLK3 protein kinases, respectively. CLK-IN-T3 has anti-cancer activity[1].
Target Antigen
CDK; DYRK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/clk-in-t3.html
Purity
98.63
Solubility
DMSO : 4.83 mg/mL (ultrasonic;warming)
Smiles
CC(C1=CC=C(C(NC2=CN3C=C(C4=CC=NC=C4)C=CC3=N2)=O)C=C1)(C)C(N5CCN(C)CC5)=O
Molecular Weight
482.58
References & Citations
[1]Funnell T, et al. CLK-dependent exon recognition and conjoined gene formation revealed with a novel smallmolecule inhibitor. Nat Commun. 2017 Feb 23;8(1):7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-115470/CLK-IN-T3-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-115470/CLK-IN-T3-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2109805-56-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6358678-01 0.1 mL
TRIP4, ID (TRIP4, Activating signal cointegrator 1, Thyroid receptor-interacting protein 4) (MaxLight 550)
Ask
View Details